. The drug works by targeting the nicotine receptors in the brain, CEO. “It works to reduce the satisfaction you get while smoking, but also helps with the cravings and withdrawal symptoms.”
The study, which followed 792 patients, had patients take the drug for either 6 weeks or 12 weeks. Both patients who received the drug and those who got a placebo also went through a behavioral program about quitting smoking. The company says that over 30% of those who took the drug for 12 weeks stopped smoking completely in the last four weeks of the study, compared to less than 10% in the placebo group.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: